Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125417161 | 12541716 | 1 | I | 20160527 | 20160701 | 20160708 | 20160708 | EXP | FR-UCBSA-2016025035 | UCB | 50.98 | YR | M | Y | 0.00000 | 20160708 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125417161 | 12541716 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, ONCE DAILY (QD) | 21035 | 500 | MG | QD | |||||||
| 125417161 | 12541716 | 2 | SS | Oracilline | PENICILLIN V | 1 | UNK | Y | U | 0 | |||||||||
| 125417161 | 12541716 | 3 | SS | BRICANYL | TERBUTALINE SULFATE | 1 | UNK | Y | U | 0 | |||||||||
| 125417161 | 12541716 | 4 | SS | Urbanyl | CLOBAZAM | 1 | Oral | 10 MG, ONCE DAILY (QD) | U | U | 0 | 10 | MG | QD | |||||
| 125417161 | 12541716 | 5 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Intravenous (not otherwise specified) | 1 G 3/DAY | U | U | 0 | TID | |||||||
| 125417161 | 12541716 | 6 | SS | ATROVENT | IPRATROPIUM BROMIDE | 1 | UNK | U | U | 0 | |||||||||
| 125417161 | 12541716 | 7 | SS | Piperacillin | PIPERACILLIN | 1 | Intravenous (not otherwise specified) | UNK | U | U | 0 | ||||||||
| 125417161 | 12541716 | 8 | SS | Rovamycine | SPIRAMYCIN | 1 | UNK | U | U | 0 | |||||||||
| 125417161 | 12541716 | 9 | C | Triatec | RAMIPRIL | 1 | UNK | U | 0 | ||||||||||
| 125417161 | 12541716 | 10 | C | RETROVIR | ZIDOVUDINE | 1 | UNK | U | 0 | ||||||||||
| 125417161 | 12541716 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | 0 | ||||||||||
| 125417161 | 12541716 | 12 | C | Ventoline | ALBUTEROL | 1 | UNK, AS NEEDED (PRN) | U | 0 | ||||||||||
| 125417161 | 12541716 | 13 | C | Alfuzosin | ALFUZOSIN | 1 | 10 MG/ DAY | U | 0 | ||||||||||
| 125417161 | 12541716 | 14 | C | Un alfa | ALFACALCIDOL | 1 | 1 ?G/DAY | U | 0 | ||||||||||
| 125417161 | 12541716 | 15 | C | Coumadine | WARFARIN SODIUM | 1 | 2 MG/DAY | U | 0 | ||||||||||
| 125417161 | 12541716 | 16 | C | Levothyrox | LEVOTHYROXINE | 1 | 75 ?G/DAY | U | 0 | ||||||||||
| 125417161 | 12541716 | 17 | C | Paracetamol | ACETAMINOPHEN | 1 | 1 G/DAY | U | 0 | ||||||||||
| 125417161 | 12541716 | 18 | C | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | 400 MG MORNING AND EVENING | U | 0 | ||||||||||
| 125417161 | 12541716 | 19 | C | Tenofovir | TENOFOVIR | 1 | 1 DF, ONCE DAILY (QD) | U | 0 | 1 | DF | TABLET | QD | ||||||
| 125417161 | 12541716 | 20 | C | Inexium | ESOMEPRAZOLE | 1 | 20 MG/ DAY | U | 0 | ||||||||||
| 125417161 | 12541716 | 21 | C | Calcium carbonate w/colecalciferol | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 500 MG 3/DAY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125417161 | 12541716 | 1 | Product used for unknown indication |
| 125417161 | 12541716 | 2 | Product used for unknown indication |
| 125417161 | 12541716 | 3 | Product used for unknown indication |
| 125417161 | 12541716 | 4 | Product used for unknown indication |
| 125417161 | 12541716 | 5 | Product used for unknown indication |
| 125417161 | 12541716 | 6 | Product used for unknown indication |
| 125417161 | 12541716 | 7 | Product used for unknown indication |
| 125417161 | 12541716 | 8 | Product used for unknown indication |
| 125417161 | 12541716 | 9 | Product used for unknown indication |
| 125417161 | 12541716 | 10 | Product used for unknown indication |
| 125417161 | 12541716 | 11 | Product used for unknown indication |
| 125417161 | 12541716 | 12 | Product used for unknown indication |
| 125417161 | 12541716 | 13 | Product used for unknown indication |
| 125417161 | 12541716 | 14 | Product used for unknown indication |
| 125417161 | 12541716 | 15 | Product used for unknown indication |
| 125417161 | 12541716 | 16 | Product used for unknown indication |
| 125417161 | 12541716 | 18 | Product used for unknown indication |
| 125417161 | 12541716 | 19 | Product used for unknown indication |
| 125417161 | 12541716 | 20 | Product used for unknown indication |
| 125417161 | 12541716 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125417161 | 12541716 | OT |
| 125417161 | 12541716 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125417161 | 12541716 | Acute kidney injury | |
| 125417161 | 12541716 | Cell death | |
| 125417161 | 12541716 | Cholestasis | |
| 125417161 | 12541716 | Inflammation | |
| 125417161 | 12541716 | Lactic acidosis | |
| 125417161 | 12541716 | Off label use | |
| 125417161 | 12541716 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125417161 | 12541716 | 3 | 20160527 | 20160530 | 0 | |
| 125417161 | 12541716 | 5 | 20160527 | 20160530 | 0 | |
| 125417161 | 12541716 | 6 | 20160528 | 0 | ||
| 125417161 | 12541716 | 7 | 20160528 | 0 | ||
| 125417161 | 12541716 | 8 | 20160528 | 20160530 | 0 | |
| 125417161 | 12541716 | 13 | 20150824 | 0 | ||
| 125417161 | 12541716 | 14 | 20150824 | 0 | ||
| 125417161 | 12541716 | 15 | 20150824 | 0 | ||
| 125417161 | 12541716 | 16 | 20150824 | 0 | ||
| 125417161 | 12541716 | 17 | 20150824 | 0 | ||
| 125417161 | 12541716 | 18 | 20150824 | 0 | ||
| 125417161 | 12541716 | 19 | 20150824 | 0 | ||
| 125417161 | 12541716 | 20 | 20150824 | 0 |